Khalid Canna

1.7k citations
14 papers · 1.5k · h-index 9

Impact in

  • Oncology top 5%
    • Inflammatory Biomarkers in Disease Prognosis
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Surgical Treatments
    • Pancreatic and Hepatic Oncology Research
    • Cancer, Lipids, and Metabolism

Papers in

    • Inflammatory Biomarkers in Disease Prognosis 8
    • Cancer Immunotherapy and Biomarkers 3
    • Gastrointestinal disorders and treatments 4
    • Diverticular Disease and Complications 2
    • Urinary and Genital Oncology Studies 2

Khalid Canna

13 papers receiving 1.5k citations

Peers

Khalid Canna
Comparison fields: 5 of 68
  • Oncology 936
  • Cancer Research 138
  • Immunology 148
  • Pulmonary and Respiratory Medicine 205
  • Hepatology 40
Replace Hitoshi Nagata with:
Hitoshi Nagata Japan
Renate Schaberl-Moser Austria
Cun Liao China
Laura Ferrari Italy
Jianping Xiong China
Ulla Klaiber Germany
Chang‐Hsien Lu Taiwan
Yukimasa Miyazawa Japan
Kazunaga Ishigaki Japan
Chung Rong Changchien Taiwan
Khalid Canna relative to Hitoshi Nagata Japan Hitoshi Nagata's profile →
Citations per field
00.5×1.7×
Hitoshi Nagata · 1×
Citations per year

Countries citing papers authored by Khalid Canna

Since Specialization
Citations

This map shows the geographic impact of Khalid Canna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Canna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Canna more than expected).

Fields of papers citing papers by Khalid Canna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Canna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Canna. The network helps show where Khalid Canna may publish in the future.

Co-authors

The 21 scholars most cited alongside Khalid Canna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Khalid Canna Line = papers co-authored together Khalid Canna links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 2007467
2 2003412
3 2005202
4 2003139
5 2004101
6 200466
7 200158
8 200726
9 200321
10 20146
11 20174
12 20212
13 20211
14 20250

About Khalid Canna

Khalid Canna is a scholar working on Oncology, Surgery, Psychiatry and Mental health, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 1.5k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (8 papers), Gastrointestinal disorders and treatments (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Diverticular Disease and Complications (2 papers), Urinary and Genital Oncology Studies (2 papers), Gallbladder and Bile Duct Disorders (1 paper) and Adipokines, Inflammation, and Metabolic Diseases (1 paper). The work is most often cited by research in Oncology (936 citations), Cancer Research (138 citations), Immunology (148 citations), Pulmonary and Respiratory Medicine (205 citations) and Hepatology (40 citations). Khalid Canna has collaborated with scholars based in United Kingdom, United Arab Emirates and Egypt. Frequent co-authors include Donald C. McMillan, Colin S. McArdle, Wilson J. Angerson, Colin S. McArdle, J E M Crozier, A. M. McNicol, Peter A McArdle, Ruth F. McKee, E. Bromwich and Michael Aitchison. Their work appears in journals such as British Journal of Cancer, Surgical Endoscopy, Colorectal Disease, British journal of surgery and International Journal of Colorectal Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact